SINE compounds (Mount Sinai School of Medicine/Karyopharm Therapeutics)

N/A

Report date: 2025/03/20 09:52:41
NME

Base Information

Drug NameSINE compounds (Mount Sinai School of Medicine/Karyopharm Therapeutics)
Drug Alias NameCRM-1 inhibitors (Mount Sinai School of Medicine/Karyopharm Therapeutics)selective inhibitors of nuclear export (Mount Sinai School of Medicine/Karyopharm Therapeutics)XPO-1 inhibitors (Mount Sinai School of Medicine/Karyopharm Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExportin-1 protein inhibitors
TargetsExportin-1 protein
Therapy Area/IndicationsLupus Erythematosus, SystemicMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcahn School Of Medicine At Mount Sinai
China Registration ClassN/A

Develop Information

Active CompaniesKaryopharm Therapeutics IncIcahn School Of Medicine At Mount Sinai
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A